|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
TISSUE-SPECIFIC STEM CELLS |
a Stem Cell Institute,
b Department of Neurosurgery,
c Graduate Program in Neuroscience, University of Minnesota, Minneapolis, Minnesota, USA;
d Clínica Universitaria, Universidad de Navarra, Pamplona, Spain;
e Department of Cell Biology, Instituto Cavanilles and Centro de Investigacion Principe Felipe, University of Valencia, Valencia, Spain;
f Department of Neuroscience, University of Minnesota, Minneapolis, Minnesota, USA;
g Division of Neurosciences, Centre for Applied Medical Research, Pamplona, Spain
Key Words. Adult bone marrow stem cells • Label • Bromodeoxyuridine • Thymidine analog • Control • Transplantation • Neural differentiation • In vivo tracking
Correspondence: Catherine M. Verfaillie, M.D., Stem Cell Institute, Department of Medicine, University of Minnesota, 420 Delaware Street, Minneapolis, Minnesota 55455, USA. Telephone: 612-625-0602; Fax: 612-624-2436; e-mail: verfa001{at}umn.edu
Received September 22, 2005;
accepted for publication December 5, 2005.
Thymidine analogs, including bromodeoxyuridine, chlorodeoxyuridine, iododeoxyuridine, and tritiated thymidine, label dividing cells by incorporating into DNA during S phase of cell division and are widely employed to identify cells transplanted into the central nervous system. However, the potential for transfer of thymidine analogs from grafted cells to dividing host cells has not been thoroughly tested. We here demonstrate that graft-derived thymidine analogs can become incorporated into host neural precursors and glia. Large numbers of labeled neurons and glia were found 312 weeks after transplantation of thymidine analog-labeled live stem cells, suggesting differentiation of grafted cells. Remarkably, however, similar results were obtained after transplantation of dead cells or labeled fibroblasts. Our findings reveal for the first time that thymidine analog labeling may not be a reliable means of identifying transplanted cells, particularly in highly proliferative environments such as the developing, neurogenic, or injured brain.
This article has been cited by other articles:
![]() |
H. Reinecke, E. Minami, W.-Z. Zhu, and M. A. Laflamme Cardiogenic Differentiation and Transdifferentiation of Progenitor Cells Circ. Res., November 7, 2008; 103(10): 1058 - 1071. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Reumers, C. M. Deroose, O. Krylyshkina, J. Nuyts, M. Geraerts, L. Mortelmans, R. Gijsbers, C. Van den Haute, Z. Debyser, and V. Baekelandt Noninvasive and Quantitative Monitoring of Adult Neuronal Stem Cell Migration in Mouse Brain Using Bioluminescence Imaging Stem Cells, September 1, 2008; 26(9): 2382 - 2390. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-S. Kim, S.-W. Yoo, T.-S. Park, S.-C. Ahn, H.-S. Jeong, J.-W. Kim, D.-Y. Chang, K.-G. Cho, S. U. Kim, Y. Huh, et al. Neural Induction with Neurogenin1 Increases the Therapeutic Effects of Mesenchymal Stem Cells in the Ischemic Brain Stem Cells, September 1, 2008; 26(9): 2217 - 2228. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Pawelczyk, A. S. Arbab, A. Chaudhry, A. Balakumaran, P. G. Robey, and J. A. Frank In Vitro Model of Bromodeoxyuridine or Iron Oxide Nanoparticle Uptake by Activated Macrophages from Labeled Stem Cells: Implications for Cellular Therapy Stem Cells, May 1, 2008; 26(5): 1366 - 1375. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Kamiya, Y. Fujinami, N. Hoya, Y. Okamoto, H. Kouike, R. Komatsuzaki, R. Kusano, S. Nakagawa, H. Satoh, M. Fujii, et al. Mesenchymal Stem Cell Transplantation Accelerates Hearing Recovery through the Repair of Injured Cochlear Fibrocytes Am. J. Pathol., July 1, 2007; 171(1): 214 - 226. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Almond, R. M Lindley, S. E Kenny, M G. Connell, and D. H Edgar Characterisation and transplantation of enteric nervous system progenitor cells Gut, April 1, 2007; 56(4): 489 - 496. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. M. Coyne, A. J. Marcus, D. Woodbury, and I. B. Black Marrow Stromal Cells Transplanted to the Adult Brain Are Rejected by an Inflammatory Response and Transfer Donor Labels to Host Neurons and Glia Stem Cells, November 1, 2006; 24(11): 2483 - 2492. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Kunter, S. Rong, Z. Djuric, P. Boor, G. Muller-Newen, D. Yu, and J. Floege Transplanted Mesenchymal Stem Cells Accelerate Glomerular Healing in Experimental Glomerulonephritis J. Am. Soc. Nephrol., August 1, 2006; 17(8): 2202 - 2212. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| STEM CELLS | THE ONCOLOGIST | CME | ALPHAMED PRESS JOURNALS |
